Chronic diseases often lead to fibrosis, a condition in which organ tissue suffers from excessive scarring. Researchers at the University of Zurich have now developed an immunotherapy that specifically targets the cause—activated ...
Sep 15, 2022
0
36
An experimental cancer drug with a favorable safety profile shows promise as a treatment for Idiopathic Pulmonary Fibrosis (IPF), according to a study published on August 23, 2022, in the American Journal of Respiratory and ...
Sep 1, 2022
0
301
Cystic fibrosis (CF) is a life-threatening genetic disorder, marked by recurrent infections resulting in chronic lung inflammation. Unfortunately, the mechanisms underlying this inflammation are not fully elucidated. In this ...
Aug 26, 2022
0
4
Heard about the chia seed-lemon juice "internal shower" drink? It's going viral on TikTok and is being hailed as a digestion booster, constipation and bloating buster (particularly after traveling), detox drink and hangover ...
Aug 26, 2022
0
5
A substance produced by gut microorganisms can lead to scarring and blood vessel damage in patients with scleroderma, a new study suggests.
Aug 24, 2022
0
36
Webster Santos is determined to find a way to halt kidney fibrosis, a condition caused by persistent inflammation and assault to the kidney. The disorder leads to kidney disease, itself a pathway to kidney failure, also known ...
Aug 22, 2022
1
264
Researchers have successfully engineered human immune cells to model an infection common among immunocompromised people in a discovery that paves the way for new drug testing and treatments.
Aug 18, 2022
0
100
Cystic fibrosis remains an incurable genetic disorder that impairs lung function and significantly reduces life expectancy. A new combination drug therapy that addresses the disorder's underlying defects offers a promising ...
Aug 8, 2022
0
13
The QUT Inspire ISy app, was developed by QUT Ph.D. candidate Clarence Baxter and has been tested and compared with a Triflo II clinical incentive spirometry device by 24 healthy participants with the study's results published ...
Jul 28, 2022
0
7
A Nagoya University research group has developed an AI algorithm that accurately and quickly diagnoses idiopathic pulmonary fibrosis, a lung disease. The algorithm makes its diagnosis based only on information from non-invasive ...
Jul 28, 2022
0
5
